Coherus BioSciences
CHRS
$2.06
Share price
1.23%
Change (1 day)
-71.44%
Change (1 year)
Categories
Coherus BioSciences (CHRS) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.2 B
According to Coherus BioSciences
's latest financial reports the company has -$0.2 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Coherus BioSciences - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-0.14 B | -240.62% |
| 2021-12-31 | $97.72 M | -65.22% |
| 2020-12-31 | $0.28 B | 167.05% |
| 2019-12-31 | $0.10 B | -372.64% |
| 2018-12-31 | $-38.6 M | -226.38% |
| 2017-12-31 | $30.53 M | 57.77% |
| 2016-12-31 | $19.35 M | -379.32% |
| 2015-12-31 | $-6.93 M | -110.38% |
| 2014-12-31 | $66.75 M | -257.51% |
| 2013-12-31 | $-42.39 M | -561.07% |
| 2012-12-31 | $9.19 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.23 B | -3,321.92% | 🇺🇸 USA |
 Repligen
RGEN | $1.97 B | -1,119.10% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.16 B | -18.34% | 🇺🇸 USA |